MusclePharm (MusclePharm) Days Payable : 145.07 (As of Mar. 2022)

View and export this data going back to 2008. Start your Free Trial

What is MusclePharm Days Payable?

MusclePharm's average Accounts Payable for the three months ended in Mar. 2022 was $18.43 Mil. MusclePharm's Cost of Goods Sold for the three months ended in Mar. 2022 was $11.59 Mil. Hence, MusclePharm's Days Payable for the three months ended in Mar. 2022 was 145.07.

The historical rank and industry rank for MusclePharm's Days Payable or its related term are showing as below:

MSLPQ's Days Payable is not ranked ^*
in the Consumer Packaged Goods industry.
Industry Median: 45.7
* Ranked among companies with meaningful Days Payable only.

MusclePharm's Days Payable increased from Mar. 2021 (137.76) to Mar. 2022 (145.07). It may suggest that MusclePharm delayed paying its suppliers.

MusclePharm Days Payable Historical Data

The historical data trend for MusclePharm's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MusclePharm Days Payable Chart

MusclePharm Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Days Payable

Get a 7-Day Free Trial

54.38

95.65

131.07

166.49

133.59

MusclePharm Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Days Payable	Get a 7-Day Free Trial															137.76	103.87	129.85	158.64	145.07

Competitive Comparison of MusclePharm's Days Payable

For the Packaged Foods subindustry, MusclePharm's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MusclePharm's Days Payable Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, MusclePharm's Days Payable distribution charts can be found below:

* The bar in red indicates where MusclePharm's Days Payable falls into.

MusclePharm Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

MusclePharm's Days Payable for the fiscal year that ended in Dec. 2021 is calculated as

	Days Payable (A: Dec. 2021 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2020 )	+	Accounts Payable (A: Dec. 2021 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2021 )	*	Days in Period
=	( (14.719	+	17.98)	/	2 )	/	44.671	*	365
=	16.3495					/	44.671	*	365
=	133.59

MusclePharm's Days Payable for the quarter that ended in Mar. 2022 is calculated as:

	Days Payable (Q: Mar. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2021 )	+	Accounts Payable (Q: Mar. 2022 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2022 )	*	Days in Period
=	( (17.98	+	18.877)	/	2 )	/	11.592	*	365 / 4
=	18.4285					/	11.592	*	365 / 4
=	145.07

MusclePharm Days Payable Related Terms

Thank you for viewing the detailed overview of MusclePharm's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

MusclePharm (MusclePharm) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » MusclePharm Corp (OTCPK:MSLPQ) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

6728 W. Sunset Road, Suite 130, Las Vegas, NV, USA, 89118

Website

https://www.musclepharmcorp.com

MusclePharm Corporation is a performance lifestyle company. It develops, manufactures, markets and distributes branded nutritional supplements. It offers various types of powders, capsules, tablets and gels. Geographically, the firm has its business presence across the region of US and in the international market of which the US accounts for the majority of revenue. MusclePharm's Hybrid series products include Assault, Combat Protein Powder, BCAA 3:1:2, CLA Core, Fish Oil, Combat Crunch Protein Bars, glutamine, carnitine, Combat Crunch, Protein Crisp, Organic Protein, and Protein Cookie. The group sells its products to various fitness enthusiasts, such as professional, combat sport, weight training, bodybuilding, running, and various team and individual sports, and others.

Executives

Eric Chin	officer: Chief Accounting Officer	1668 S. GARFIELD AVE., 2ND FLOOR, ALHAMBRA CA 91801
Paul W Karr	director	BRISTOL MEYERS SQUIBB CO, 345 PARK AVENUE, NEW YORK NY 10154
Sabina Rizvi	officer: President & CFO	6728 W. SUNSET ROAD, SUITE 130, LAS VEGAS NV 89118
Michael David Heller	director	4500 PARK GRANADA, SUITE 202, CALABASAS CA 91302
Wynnefield Partners Small Cap Value Lp I	10 percent owner	450 SEVENTH AVENUE, SUITE 509, NEW YORK NY 10123
Donald Feagan	10 percent owner	2150 SOUTH 1300 EAST STREET, SUITE 500, SALT LAKE CITY UT 84106
Amerop Holdings, Inc.	10 percent owner	1800 BROADWAY, SUITE 100, BOULDER CO 80302
White Winston Select Asset Fund Series Fund Mp-18, Llc	10 percent owner	C/O WHITE WINSTON SELECT ASSET FUNDS, LLC, 265 FRANKLIN ST., SUITE 1702, BOSTON MA 02110
Robert P Mahoney	10 percent owner	4 DANIELS FARM ROAD, #305, TRUMBULL CT 06611
White Winston Select Asset Funds, Llc	10 percent owner	265 FRANKLIN STREET, SUITE 1702, BOSTON MA 02110
Todd M. Enright	10 percent owner	2150 SOUTH 1300 EAST STREET, SUITE 500, SALT LAKE CITY UT 84106
Mark Blundell	10 percent owner	8 MACDONALD AVE, ARMOUK NY 10504
John J Desmond	director	10 GLEN HEAD ROAD, GLEN HEAD NY 11545
Wynnefield Small Cap Value Offshore Fund Ltd	10 percent owner	450 SEVENTH AVE, STE 509, NEW YORK NY 10123
Wynnefield Capital Inc	10 percent owner	450 SEVENTH AVE, STE 509, NEW YORK NY 10123